Insider profile
Insider profile
Insider profile
Average trade metrics summarize scored disclosures individually. Backtests simulate portfolio allocation over time.
Trades Analyzed
4
Avg Trade Return
17.6%
Avg Trade Alpha
18.5%
Win Rate
75%
Avg Holding Days
17
Company stock with this insider's own disclosed trades.
Displayed quotes are USD. Current foreign prices use spot FX where applicable; historical foreign filing prices use trade-date FX and ADR ratios when normalized. Original reported prices remain shown below.
Jun 12, 2026 · purchase
7.5%
Return
7.2%
Alpha
Summit Therapeutics Inc.
Pulse Biosciences, Inc.
Pulse Biosciences, Inc.
Company stock
Showing this insider's disclosed buys and sells only.
Market Cap
Unavailable
Current Price
$14.01
Day Change
--
Day %
--
Day Volume
—
Avg. Volume (30D)
5.41M
Trailing P/E
—
Beta
—